Comparison between Concord Biotech IPO and Netweb Technologies IPO.
Concord Biotech IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Netweb Technologies IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Concord Biotech IPO is up to ₹1,550.52 Cr whereas the issue size of the Netweb Technologies IPO is up to ₹631.00 Cr. The final issue price of Concord Biotech IPO is ₹741.00 per share and of Netweb Technologies IPO is ₹500.00 per share.
| Concord Biotech IPO | Netweb Technologies IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹2 per share |
| Issue Price (Lower) | ₹705.00 per share | ₹475.00 per share |
| Issue Price (Upper) | ₹741.00 per share | ₹500.00 per share |
| Issue Price (Final) | ₹741.00 per share | ₹500.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹70.00 per share | ₹25.00 per share |
| Market Lot Size | 20 shares | 30 shares |
| Fresh Issue Size | 0 shares | 41,21,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹206.03 Cr |
| OFS Issue Size | 2,09,25,652 shares | 85,00,000 shares |
| OFS Issue Size (Amount) | up to ₹1,550.52 Cr | up to ₹424.97 Cr |
| Issue Size Total | 2,09,25,652 shares | 1,26,21,000 shares |
| Issue Size Total (Amount) | up to ₹1,550.52 Cr | up to ₹631.00 Cr |
Concord Biotech IPO opens on Aug 04, 2023, while Netweb Technologies IPO opens on Jul 17, 2023. The closing date of Concord Biotech IPO and Netweb Technologies IPO is Aug 08, 2023, and Jul 19, 2023, respectively.
| Concord Biotech IPO | Netweb Technologies IPO | |
|---|---|---|
| Anchor Bid Date | Aug 03, 2023 | Jul 14, 2023 |
| Issue Open | Aug 04, 2023 | Jul 17, 2023 |
| Issue Close | Aug 08, 2023 | Jul 19, 2023 |
| Basis Of Allotment (Tentative) | Aug 11, 2023 | Jul 24, 2023 |
| Initiation of Refunds (Tentative) | Aug 14, 2023 | Jul 25, 2023 |
| Credit of Share (Tentative) | Aug 17, 2023 | Jul 26, 2023 |
| Listing date (Tentative) | Aug 18, 2023 | Jul 27, 2023 |
| Anchor Lockin End date 1 | Sep 10, 2023 | Aug 23, 2023 |
| Anchor Lockin End date 2 | Nov 09, 2023 | Oct 22, 2023 |
Concord Biotech IPO P/E ratio is 32.29, as compared to Netweb Technologies IPO P/E ratio of 59.67.
| Concord Biotech IPO | Netweb Technologies IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 44.08 | 97.80 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 44.08 | 75.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 32.29 | 59.67 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹7752.06 Cr. | ₹2803.20 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 20.06% | 68.01% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.27% | 64.42% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.30 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹20.79 | ₹9.22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20% | 68.01% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Concord Biotech IPO Retail Individual Investors (RII) are offered 73,20,479 shares while in Netweb Technologies IPO retail investors are offered 73,20,479 shares. Qualified Institutional Buyers (QIB) are offered 41,83,130 shares in Concord Biotech IPO and 25,20,200 shares in Netweb Technologies IPO.
| Concord Biotech IPO | Netweb Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | 62,74,695 shares | 37,80,300 shares |
| Market Maker Reservation | ||
| QIB | 41,83,130 shares | 25,20,200 shares |
| NII | 31,37,348 shares | 18,90,150 shares |
| RII | 73,20,479 shares | 44,10,350 shares |
| Employee | 10,000 shares | 20,000 shares |
| Others | ||
| Total | 2,09,25,652 shares | 1,26,21,000 shares |
Concord Biotech IPO subscribed 24.87x in total, whereas Netweb Technologies IPO subscribed 90.55x.
| Concord Biotech IPO | Netweb Technologies IPO | |
|---|---|---|
| QIB (times) | 67.67x | 220.69x |
| NII (times) | 16.99x | 83.21x |
| Big NII (times) | 19.30x | 88.29x |
| Small NII (times) | 12.37x | 73.07x |
| RII (times) | 3.78x | 19.48x |
| Employee (times) | 24.48x | 55.92x |
| Other (times) | ||
| Total (times) | 24.87x | 90.55x |
